Brian G. Drazba, MEI Pharma's Chief Financial Officer, just received 200,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Drazba now owns at least 200,000 options on the company.
Some additional info was provided as follows:
One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All of such options are presently exercisable.
One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018.
One-quarter of such options vested on June 22, 2019 and the remaining thre
e-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!
